Evolution of the Average Target: Boule Diagnostics AB

Evolution of the Average Target - Boule Diagnostics AB

Evolution of the Target Price: Boule Diagnostics AB

Evolution of the Target Price - Boule Diagnostics AB

Changes in Analyst Recommendations: Boule Diagnostics AB

e699e7cf05c2d5e80422e29e6.mHZHTBwuYHOnR05ZlRda7V1QkOaBlm2jc4nD1PeYioc.6i5-flNgJAefIB8b5HsXpWw1oYLZwyHLCr-FuJHM_cThIBItVBcIHp8NLQ~8a148c682d2d5ab8fbc3b25cdb19a049
09-08 Affärsvärlden Is Not Tempted by Boule Diagnostics, Neutral Rating FW
04-29 Weak performance prompts Pareto to downgrade Boule Diagnostics to Hold FW
04-29 Pareto Securities downgrades Boule Diagnostics to hold (buy), sets price target at SEK 3.80 (6.50) FW
02-12 Pareto Securities Lowers Price Target for Boule Diagnostics to 6.50 Kronor (7.50), Reiterates Buy FW
21/07/25 Pareto Securities Lowers Price Target for Boule Diagnostics to SEK 7.50 (10.30), Reiterates Buy Recommendation FW
13/06/25 Pareto reiterates buy recommendation for Boule – return to positive organic growth expected FW
13/06/25 Pareto Securities lowers its target price for Boule Diagnostics to SEK 10.30 (10.50), reiterates buy recommendation FW
13/03/25 Pareto makes minor cut in target price for Boule Diagnostics FW
10/03/25 Di lists seven potential bid candidates FW
12/02/25 Pareto reiterates buy for Boule - discount to peer group expected to narrow FW
12/02/25 Pareto Securities raises target price for Boule Diagnostics to SEK 11 (10.50), reiterates Buy FW
04/02/25 Pareto reiterates Buy for Boule - sales not expected to be much affected by US tariffs FW
04/02/25 Pareto Securities raises target price for Boule Diagnostics to SEK 10.50 (9.5), reiterates Buy FW
28/10/24 Pareto Securities raises Boule Diagnostics to Buy (Hold), target price SEK 9.5 (9) FW
09/10/24 Pareto reiterates 'hold' for Boule - does not rule out more major costs in the near future FW
09/10/24 Pareto Securities lowers target price for Boule Diagnostics to SEK 9 (9.50), reiterates 'hold' rating FW
08/10/24 Business World remains neutral on Boule Diagnostics after write-down FW
23/07/24 Pareto Securities lowers target price for Boule Diagnostics to SEK 9.50 (10.90), reiterates 'hold' rating FW
08/05/24 Pareto Securities raises target price for Boule Diagnostics to SEK 10.90 (10.40), reiterates 'hold' rating FW
12/04/24 Boule Diagnostics falls slightly after Pareto lowers its target price FW
12/04/24 Pareto Securities lowers target price for Boule Diagnostics to SEK 10.40 (12.50), reiterates 'hold' rating FW
07/02/24 Business World stays at a neutral advice for Boule Diagnostics FW
07/02/24 Pareto lowers Boule Diagnostics to hold - does not rule out need for additional capital FW
07/02/24 Pareto Securities downgrades Boule Diagnostics to Hold (Buy), target price SEK 12.50 (12) FW
10/11/23 Pareto Securities lowers target price for Boule Diagnostics to SEK 12 (12.50), reiterates Buy FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - +267.15%
+6.05%
+9.67%
+7.55%
+21.79%
+7.86%
+5.84%
+0.5%
-2.97%
-2.96%
Average +32.05%
Weighted average by Cap. +6.87%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.035SEK
Average target price
3.800SEK
Spread / Average Target
+267.15%
High Price Target
3.800SEK
Spread / Highest target
+267.15%
Low Price Target
3.800SEK
Spread / Lowest Target
+267.15%

Analyst Consensus Detail

Analyst consensus - Boule Diagnostics AB

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Boule Diagnostics AB
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Boule Diagnostics AB
  1. Stock Market
  2. Stocks
  3. BOUL Stock
  4. Consensus Boule Diagnostics AB